Ibuprofen, aspirin for platelet aggregation inhibition
This article was originally published in The Tan Sheet
Executive SummaryTaking 325 mg of aspirin followed by 400 mg of ibuprofen significantly reduces the magnitude and duration of inhibition of platelet aggregation, according to a study in the April Journal of Clinical Pharmacology. Researchers led by Francis M. Gengo, a pharmacy professor at State University of New York at Buffalo, conducted the study with 10 subjects taking either 325 mg of aspirin, 400 mg of aspirin or 400 mg of ibuprofen followed by 325 mg of aspirin two hours later. The researchers also conducted a confirmatory study for 27 months with 28 patients...
You may also be interested in...
Abbott is encouraged by results from two studies of its Proclaim XR neurostimulation system for chronic pain, presented at the annual North American Neuromodulation Society (NANS) meeting in Las Vegas. See what Steven Falowski of Neurosurgical Associates of Lancester in Pennsylvania said about it here.
While disappointing result will probably put an end to single-drug plans in ovarian cancer, the blockbuster anti-PD-1 immunotherapy remains in combination development for the indication.
According to the plaintiff, Unilever’s Pond’s Rejuveness Anti-Wrinkle Cream is defective insofar as tested product has been found to contain unlabeled mercury, constituting negligence that has resulted in user injuries. The plaintiff seeks certification of a transnational class and compensatory and punitive damages, among other relief.